Category: MasimoSyndicate content

D+Vice Talk - June 7, 2013 with guest speaker Stephen Simpson, medtech analyst

June 7, 2013 by Arezu Sarvestani

See video

Welcome to the latest edition of the MassDevice.com's D+Vice Talk, our new webcast, in which we review medical device stories from the last week.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Masimo throws down the gauntlet with $1M challenge against Covidien

May 31, 2013 by Arezu Sarvestani

Masimo offers $1 million to any hospital that proves that its Masimo SET pulse oximeters are less accurate that Covidien's Nellcor devices.

arm wrestling

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medical device tax: How much are companies paying to government for healthcare reform?

May 15, 2013 by Brian Johnson

A list of some of the tax tabs for medical device companies for the medical device excise tax during Q1

MassDevice.com coverage of the medical device tax

In January 2013, Medical device companies began paying a 2.3% excise tax on U.S. Sales in order to pay for the Patient Protection and Affordable Care Act.

The levy is expected to generate some $30 billion over the next 10 years.

MassDevice.com is tracking the tally paid by several medical device companies, based on quarterly earnings report for the first quarter of 2013. We will update the list as more companies returns file in.

Tallies based on companies with Q1 earnings ended on March 31, 2013

Masimo lands FDA win for pediatric acoustic sensor

May 8, 2013 by Sony Salzman

FDA regulators give Masimo a nod for its Rainbow acoustic monitoring sensor for pediatric use.

Masimo

The FDA granted 510(k) clearance to Masimo (NSDQ:MASI) for its Rainbow acoustic monitoring sensor for use in children.

Previously cleared for adults, the device can now be used in the U.S. to monitor the respiration rate of pediatric patients.

Masimo gains on Q1 numbers, affirmed guidance

May 6, 2013 by Brad Perriello

Shares of medical device company Masimo gain on solid 1st-quarter sales and earnings and affirmed sales guidance for the rest of 2013.

Masimo

Masimo (NSDQ:MASI) shares are up following the Irvine, Calif.-based medical device company's solid 1st-quarter results, gaining some 7% since last week's earnings announcement.

Masimo, which makes patient monitoring equipment, posted profits of $16.4 million, or 28¢ per share, on sales of $135.9 million during the 3 months ended March 30, for bottom-line growth of 4.1% and a top-line gain of 14.0%.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Masimo's Q4 sales jump 18%, but 2012 profits drop 2%

February 22, 2013 by Sony Salzman

Medical device company Masimo closes the year strong with an 18% bump in Q4 sales, but 2012 profits slip 2%.

http://www.massdevice.com/sites/default/files/logos/masi-100x100.jpg

Masimo (NSDQ:MASI) shares are down more than 1% since the medical device company reported its full-year and 4th-quarter results Feb. 14.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

N.J. doc admits to collecting $100K in imaging kickbacks | MassDevice.com On Call

February 19, 2013 by MassDevice staff

A New Jersey cardiologists admits to collecting more than $100,000 in illegal kickbacks for MRI and computed tomography referrals.

MassDevice On Call

MASSDEVICE ON CALL — New Jersey cardiologist Dr. Shashi Agarway last week admitted to collecting more than $100,000 in kickbacks for referring patients for imaging diagnostic exams.

Agarway pleaded guilty to referring patients for MRI and computed tomography scanning at Orange Community MRI in exchange for cash. He told regulators that he received $100 for each Medicare or Medicaid patient he referred for MRI scanning and $50 for each CAT scan.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp